Quick, one-time identity verification to unlock full ePrescribing access.
Encrypted data storage with secure authentication and verified prescriber identity.
Fast, streamlined prescribing from your phone – no EMR login required.
Securely access past prescription data for easy refills and reference.
Enter patient details
Select medication and strength
Add patient directions
Sign and sendA quick, one-time identity check is required before prescribing to ensure patient safety and compliance. Identity is verified by Persona, a third-party identity verification service.
Get Started FreeSend prescriptions to major U.S. pharmacies with real-time tracking and live support to ensure smooth, accurate delivery.
Receive pharmacy messages and refill alerts. Stay away from the desk without falling behind on patient care.
DocUpdate is available to licensed U.S. healthcare providers who are authorized to prescribe medications. This includes physicians (MD, DO), dentists (DDS, DMD), podiatrists (DPM), nurse practitioners (NP, APRN), physician assistants (PA), and optometrists (OD), in accordance with each state's scope of practice.
Yes. DocUpdate is fully HIPAA-compliant and operates under a formal Business Associate Agreement (BAA). We protect all Protected Health Information (PHI) using industry-standard encryption, restrict access and disclosures to the minimum necessary, and promptly report any incidents as required by law. We take data privacy and security extremely seriously. View our full BAA.
We work with 95% of US pharmacies — non-controlled prescriptions can be sent nationwide.
Yes, DocUpdate is completely free for providers. We keep it free by partnering with select, specialty-relevant pharma companies to share curated updates relevant to your practice. These messages are delivered by DocUpdate, not by third-party marketers, and you can adjust or opt out of them here.
Send us an email at support@docupdate.io
By the time we finish dermatology residency, most of us feel confident identifying rashes, managing complex skin disease, and performing procedures efficiently.
Rheumatoid arthritis (RA) is still too often reduced to a visual shorthand: swollen hands, tender joints, morning stiffness.
One of the most persistent misconceptions in inflammatory disease is that the severity of psoriasis predicts the severity of psoriatic arthritis (PsA).
AI chatbots have arrived everywhere: inside patient portals, clinical documentation tools, symptom checkers, and even consumer health apps.
Pharmaceutical ads on television are ubiquitous. Everyone in the USA is familiar with the shots of happy people enjoying their lives with uplifting music in the background.
Most-Favored-Nation (MFN) drug pricing sounds simple on paper: tie what the U.S. pays for certain drugs to the lowest price available in comparable countries.
By the time we finish dermatology residency, most of us feel confident identifying rashes, managing complex skin disease, and performing procedures efficiently.
Rheumatoid arthritis (RA) is still too often reduced to a visual shorthand: swollen hands, tender joints, morning stiffness.
One of the most persistent misconceptions in inflammatory disease is that the severity of psoriasis predicts the severity of psoriatic arthritis (PsA).
AI chatbots have arrived everywhere: inside patient portals, clinical documentation tools, symptom checkers, and even consumer health apps.
Pharmaceutical ads on television are ubiquitous. Everyone in the USA is familiar with the shots of happy people enjoying their lives with uplifting music in the background.
Most-Favored-Nation (MFN) drug pricing sounds simple on paper: tie what the U.S. pays for certain drugs to the lowest price available in comparable countries.
By the time we finish dermatology residency, most of us feel confident identifying rashes, managing complex skin disease, and performing procedures efficiently.
Rheumatoid arthritis (RA) is still too often reduced to a visual shorthand: swollen hands, tender joints, morning stiffness.
One of the most persistent misconceptions in inflammatory disease is that the severity of psoriasis predicts the severity of psoriatic arthritis (PsA).
AI chatbots have arrived everywhere: inside patient portals, clinical documentation tools, symptom checkers, and even consumer health apps.
Pharmaceutical ads on television are ubiquitous. Everyone in the USA is familiar with the shots of happy people enjoying their lives with uplifting music in the background.
Most-Favored-Nation (MFN) drug pricing sounds simple on paper: tie what the U.S. pays for certain drugs to the lowest price available in comparable countries.
